SARS-CoV-2 (2019-nCoV) Spike Detection ELISA Kit

COVID-19 Spike Research. [ FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. ] Temporarily not available outside of China.

SARS-CoV-2 (2019-nCoV) Spike Detection ELISA Kit: General Information

Product name
SARS-CoV-2 (2019-nCoV) Spike Detection ELISA Kit
Assay type
Solid Phase Sandwich ELISA (quantitative)
60.47 pg/mL
Assay range
156.3-10000 pg/mL
Recognizes both recombinant and natural 2019-nCoV Coronavirus spike
Materials provided
1. 96 well microplate coated with Capture Antibody
2. Detection Antibody conjugated to HRP
3. Standards
4. Wash Buffer Concentrate
5. Dilution Buffer Concentrate
6. Standard Dilution Buffer
7. Color Reagent A
8. Color Reagent B
9. Stop Solution
Product overview
This SARS-CoV-2 (2019-nCoV) Spike Detection ELISA Kit is an enzyme-linked immunosorbent assay for the quantitative measurement of 2019-nCoV Coronavirus spike protein in . It contains recombinant 2019-nCoV Coronavirus spike, and antibodies raised against the recombinant protein. This ELISA kit is complete and ready-to-use.
This ELISA Kit is shipped at ambient temperature.
Unopened Kit: Store at 2 - 8℃
Opened/Reconstituted Reagents: Please refer to CoA

SARS-CoV-2 (2019-nCoV) Spike Detection ELISA Kit: Images

This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.

SARS-CoV-2 (2019-nCoV) Spike Detection ELISA Kit: Synonyms

coronavirus spike ELISA Kit, 2019-nCoV; cov spike ELISA Kit, 2019-nCoV; ncov RBD ELISA Kit, 2019-nCoV; ncov s1 ELISA Kit, 2019-nCoV; ncov s2 ELISA Kit, 2019-nCoV; ncov spike ELISA Kit, 2019-nCoV; NCP-CoV RBD ELISA Kit, 2019-nCoV; NCP-CoV s1 ELISA Kit, 2019-nCoV; NCP-CoV s2 ELISA Kit, 2019-nCoV; NCP-CoV Spike ELISA Kit, 2019-nCoV; novel coronavirus RBD ELISA Kit, 2019-nCoV; novel coronavirus s1 ELISA Kit, 2019-nCoV; novel coronavirus s2 ELISA Kit, 2019-nCoV; novel coronavirus spike ELISA Kit, 2019-nCoV; RBD ELISA Kit, 2019-nCoV; S1 ELISA Kit, 2019-nCoV; S2 ELISA Kit, 2019-nCoV; Spike RBD ELISA Kit, 2019-nCoV

Coronavirus spike Background Information

The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1; Sia, sialic acid; O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate.
  • Shen S, et al. (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35.
  • Du L, et al. (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36.
  • Xiao X, et al. (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.
  • Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells
    Cao, Y;Su, B;Guo, X;Sun, W;Deng, Y;Bao, L;Zhu, Q;Zhang, X;Zheng, Y;Geng, C;Chai, X;He, R;Li, X;Lv, Q;Zhu, H;Deng, W;Xu, Y;Wang, Y;Qiao, L;Tan, Y;Song, L;Wang, G;Du, X;Gao, N;Liu, J;Xiao, J;Su, XD;Du, Z;Feng, Y;Qin, C;Qin, C;Jin, R;Xie, XS;
  • Ultra-sensitive nanozyme-based chemiluminescence paper test for rapid diagnosis of SARS-CoV-2 infection
    Liu, D;Ju, C;Han, C;Shi, R;Chen, X;Duan, D;Yan, J;Yan, X;
Add to Cart Successfully Add to Cart Failed Shopping cart is being updated, please wait U.S.A.